RV
Reviva Pharmaceuticals Holdings, Inc.
RVPH · OTC
$0.50 +4.17% (+$0.02)
1M +0.31%
Market Cap $6.15M
P/E Ratio -
Div. Yield -
ROE 64.39%
Bulios Fair Price
$0.66
32.0% upside
Trenutna cena
$0.5
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RVPH trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.00x
PEG N/A
P/E N/A
Growth
30 /100
Declining Book val. growth 1.00%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 11.58%
ROIC 17.07%
Asset turnover 0.00x
Debt
69 /100
Low Int. coverage 0.00x
Debt/Equity 0.01x
Current ratio 3.56x
Stability
48 /100
Moderate Profitable years 0
Beta 0.50x
EPS volatility 42.89%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RVPH
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Laxminarayan Bhat
Employees
14
Headquarters
Cupertino
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report